Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

NCT02784015 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Localized Soft Tissue Sarcoma

Interventions

DRUG: Cisplatin
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Ifosfamide
DRUG: Carboplatin
RADIATION: Radiotherapy
DRUG: Thiotepa
DRUG: Melphalan

Sponsor

Samsung Medical Center